MEI Pharma Inc (NAS:MEIP)
$ 3.16 0.085 (2.76%) Market Cap: 21.05 Mil Enterprise Value: -17.79 Mil PE Ratio: 1.19 PB Ratio: 0.64 GF Score: 57/100

Infinity Pharmaceuticals Inc and MEI Pharma Inc Merger Agreement Call - Pre-recorded Transcript

Jun 19, 2023 / 12:00PM GMT
David A. Walsey
MEI Pharma, Inc. - SVP of Corporate Affairs

Hello, and thank you for joining the MEI Pharma and Infinity Pharmaceuticals merger and clinical program overview webcast. My name is David Walsey, and I'm the Senior Vice President of Corporate Affairs at MEI Pharma. Presenting today to tell you about the potential of the pending merger are from MEI, David Urso, President and CEO; and Dr. Richard Ghalie, Chief Medical Officer. From Infinity, we are joined by Dr. Robert Ilaria, Chief Medical Officer. Subject to the approval and closing of the pending merger of the 2 companies, David and Robert will be the CEO and CMO of the combined entity, respectively. Also joining today is Dr. Ezra Cohen, a leading medical oncologist and cancer researcher recently the Chief of the Division of Hematology Oncology and Associate Director of Clinical Science at UC San Diego Moores Cancer Center.

Joining for a Q&A discussion will be Dr. Nick Abbott. Nick brings over 35 years of biotech experience including research as a bench scientist at both U.K. and U.S. companies and from Wall Street, where he was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot